Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q33641643)
Watch
English
SYK regulates mTOR signaling in AML.
scientific article
In more languages
edit
Statements
instance of
scholarly article
1 reference
stated in
Europe PubMed Central
PMC publication ID
4028963
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23535559%20AND%20SRC:MED&resulttype=core&format=json
retrieved
27 February 2020
title
SYK regulates mTOR signaling in AML
(English)
1 reference
stated in
Europe PubMed Central
PMC publication ID
4028963
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23535559%20AND%20SRC:MED&resulttype=core&format=json
retrieved
27 February 2020
author
Julia Carnevale
series ordinal
1
1 reference
stated in
Europe PubMed Central
PMC publication ID
4028963
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23535559%20AND%20SRC:MED&resulttype=core&format=json
retrieved
27 February 2020
Alexandre Puissant
series ordinal
3
1 reference
stated in
Europe PubMed Central
PMC publication ID
4028963
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23535559%20AND%20SRC:MED&resulttype=core&format=json
retrieved
27 February 2020
author name string
L Ross
series ordinal
2
1 reference
stated in
Europe PubMed Central
PMC publication ID
4028963
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23535559%20AND%20SRC:MED&resulttype=core&format=json
retrieved
27 February 2020
V Banerji
series ordinal
4
1 reference
stated in
Europe PubMed Central
PMC publication ID
4028963
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23535559%20AND%20SRC:MED&resulttype=core&format=json
retrieved
27 February 2020
R M Stone
series ordinal
5
1 reference
stated in
Europe PubMed Central
PMC publication ID
4028963
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23535559%20AND%20SRC:MED&resulttype=core&format=json
retrieved
27 February 2020
D J DeAngelo
series ordinal
6
1 reference
stated in
Europe PubMed Central
PMC publication ID
4028963
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23535559%20AND%20SRC:MED&resulttype=core&format=json
retrieved
27 February 2020
K N Ross
series ordinal
7
1 reference
stated in
Europe PubMed Central
PMC publication ID
4028963
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23535559%20AND%20SRC:MED&resulttype=core&format=json
retrieved
27 February 2020
K Stegmaier
series ordinal
8
1 reference
stated in
Europe PubMed Central
PMC publication ID
4028963
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23535559%20AND%20SRC:MED&resulttype=core&format=json
retrieved
27 February 2020
publication date
28 March 2013
1 reference
stated in
Europe PubMed Central
PMC publication ID
4028963
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23535559%20AND%20SRC:MED&resulttype=core&format=json
retrieved
27 February 2020
published in
Leukemia
1 reference
stated in
Europe PubMed Central
PMC publication ID
4028963
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23535559%20AND%20SRC:MED&resulttype=core&format=json
retrieved
27 February 2020
volume
27
1 reference
stated in
Europe PubMed Central
PMC publication ID
4028963
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23535559%20AND%20SRC:MED&resulttype=core&format=json
retrieved
27 February 2020
issue
11
1 reference
stated in
Europe PubMed Central
PMC publication ID
4028963
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23535559%20AND%20SRC:MED&resulttype=core&format=json
retrieved
27 February 2020
page(s)
2118-2128
1 reference
stated in
Europe PubMed Central
PMC publication ID
4028963
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23535559%20AND%20SRC:MED&resulttype=core&format=json
retrieved
27 February 2020
cites work
Targeting of mTORC1/2 by the mTOR kinase inhibitor PP242 induces apoptosis in AML cells under conditions mimicking the bone marrow microenvironment
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4028963
retrieved
21 June 2018
Single-cell pharmacodynamic monitoring of S6 ribosomal protein phosphorylation in AML blasts during a clinical trial combining the mTOR inhibitor sirolimus and intensive chemotherapy
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4028963
retrieved
21 June 2018
Involvement of the Syk-mTOR pathway in follicular lymphoma cell invasion and angiogenesis.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4028963
retrieved
21 June 2018
Dual mTORC2/mTORC1 targeting results in potent suppressive effects on acute myeloid leukemia (AML) progenitors
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4028963
retrieved
21 June 2018
Dual inhibition of PI3K and mTORC1/2 signaling by NVP-BEZ235 as a new therapeutic strategy for acute myeloid leukemia.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4028963
retrieved
21 June 2018
Perspectives on inhibiting mTOR as a future treatment strategy for hematological malignancies
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4028963
retrieved
21 June 2018
The fusion kinase ITK-SYK mimics a T cell receptor signal and drives oncogenesis in conditional mouse models of peripheral T cell lymphoma
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4028963
retrieved
21 June 2018
RAF inhibitors transactivate RAF dimers and ERK signalling in cells with wild-type BRAF
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4028963
retrieved
21 June 2018
Inhibition of Syk with fostamatinib disodium has significant clinical activity in non-Hodgkin lymphoma and chronic lymphocytic leukemia
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4028963
retrieved
21 June 2018
A phase I study of the mammalian target of rapamycin inhibitor sirolimus and MEC chemotherapy in relapsed and refractory acute myelogenous leukemia.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4028963
retrieved
21 June 2018
Proteomic and genetic approaches identify Syk as an AML target
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4028963
retrieved
21 June 2018
Inhibition of mammalian target of rapamycin signaling potentiates the effects of all-trans retinoic acid to induce growth arrest and differentiation of human acute myelogenous leukemia cells
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4028963
retrieved
21 June 2018
Synthetic lethal interaction between oncogenic KRAS dependency and STK33 suppression in human cancer cells
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4028963
retrieved
21 June 2018
Molecular mechanisms of mTOR-mediated translational control
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4028963
retrieved
21 June 2018
An ATP-competitive mammalian target of rapamycin inhibitor reveals rapamycin-resistant functions of mTORC1
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4028963
retrieved
21 June 2018
Age and acute myeloid leukemia: real world data on decision to treat and outcomes from the Swedish Acute Leukemia Registry
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4028963
retrieved
21 June 2018
Mouse models of non-Hodgkin lymphoma reveal Syk as an important therapeutic target
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4028963
retrieved
21 June 2018
Blockade of mTOR signaling potentiates the ability of histone deacetylase inhibitor to induce growth arrest and differentiation of acute myelogenous leukemia cells
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4028963
retrieved
21 June 2018
The identification of 2-(1H-indazol-4-yl)-6-(4-methanesulfonyl-piperazin-1-ylmethyl)-4-morpholin-4-yl-thieno[3,2-d]pyrimidine (GDC-0941) as a potent, selective, orally bioavailable inhibitor of class I PI3 kinase for the treatment of cancer
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4028963
retrieved
21 June 2018
Inhibition of mTORC1 leads to MAPK pathway activation through a PI3K-dependent feedback loop in human cancer
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4028963
retrieved
21 June 2018
Suppression of programmed cell death 4 (PDCD4) protein expression by BCR-ABL-regulated engagement of the mTOR/p70 S6 kinase pathway
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4028963
retrieved
21 June 2018
A critical role for Lyn in acute myeloid leukemia.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4028963
retrieved
21 June 2018
SYK-dependent tonic B-cell receptor signaling is a rational treatment target in diffuse large B-cell lymphoma
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4028963
retrieved
21 June 2018
RAS/ERK signaling promotes site-specific ribosomal protein S6 phosphorylation via RSK and stimulates cap-dependent translation
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4028963
retrieved
21 June 2018
Divergent cytotoxic effects of PKC412 in combination with conventional antileukemic agents in FLT3 mutation-positive versus -negative leukemia cell lines.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4028963
retrieved
21 June 2018
Programmed cell death-4 tumor suppressor protein contributes to retinoic acid-induced terminal granulocytic differentiation of human myeloid leukemia cells.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4028963
retrieved
21 June 2018
Small-molecule inhibition of the interaction between the translation initiation factors eIF4E and eIF4G
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4028963
retrieved
21 June 2018
Deregulated Syk inhibits differentiation and induces growth factor-independent proliferation of pre-B cells.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4028963
retrieved
21 June 2018
Phosphotyrosine profiling identifies the KG-1 cell line as a model for the study of FGFR1 fusions in acute myeloid leukemia
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4028963
retrieved
21 June 2018
R406, an orally available spleen tyrosine kinase inhibitor blocks fc receptor signaling and reduces immune complex-mediated inflammation
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4028963
retrieved
21 June 2018
Syk-dependent mTOR activation in follicular lymphoma cells.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4028963
retrieved
21 June 2018
A method for high-throughput gene expression signature analysis
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4028963
retrieved
21 June 2018
A lentiviral RNAi library for human and mouse genes applied to an arrayed viral high-content screen
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4028963
retrieved
21 June 2018
Genomic and expression profiling identifies the B-cell associated tyrosine kinase Syk as a possible therapeutic target in mantle cell lymphoma
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4028963
retrieved
21 June 2018
mTOR regulates cell survival after etoposide treatment in primary AML cells
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4028963
retrieved
21 June 2018
Gefitinib induces myeloid differentiation of acute myeloid leukemia
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4028963
retrieved
21 June 2018
Distinct signaling events downstream of mTOR cooperate to mediate the effects of amino acids and insulin on initiation factor 4E-binding proteins
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4028963
retrieved
21 June 2018
TEL-Syk fusion constitutively activates PI3-K/Akt, MAPK and JAK2-independent STAT5 signal pathways
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4028963
retrieved
21 June 2018
Aberrant eukaryotic translation initiation factor 4E-dependent mRNA transport impedes hematopoietic differentiation and contributes to leukemogenesis
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4028963
retrieved
21 June 2018
The serine/threonine kinase Pim-2 is a transcriptionally regulated apoptotic inhibitor
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4028963
retrieved
21 June 2018
Systematic discovery of multicomponent therapeutics
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4028963
retrieved
21 June 2018
Constitutive kinase activation of the TEL-Syk fusion gene in myelodysplastic syndrome with t(9;12)(q22;p12).
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4028963
retrieved
21 June 2018
Cytogenetic and molecular analysis of the acute monocytic leukemia cell line THP-1 with an MLL-AF9 translocation
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4028963
retrieved
21 June 2018
Differential regulation of 4E-BP1 and 4E-BP2, two repressors of translation initiation, during human myeloid cell differentiation
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4028963
retrieved
21 June 2018
Phosphorylation of the cap-binding protein eukaryotic translation initiation factor 4E by protein kinase Mnk1 in vivo
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4028963
retrieved
21 June 2018
Two acute monocytic leukemia (AML-M5a) cell lines (MOLM-13 and MOLM-14) with interclonal phenotypic heterogeneity showing MLL-AF9 fusion resulting from an occult chromosome insertion, ins(11;9)(q23;p22p23).
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4028963
retrieved
21 June 2018
The t(10;11)(p13;q14) in the U937 cell line results in the fusion of the AF10 gene and CALM, encoding a new member of the AP-3 clathrin assembly protein family
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4028963
retrieved
21 June 2018
Syk tyrosine kinase required for mouse viability and B-cell development
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4028963
retrieved
21 June 2018
Criteria for analyzing interactions between biologically active agents
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4028963
retrieved
21 June 2018
The HL-60 transforming sequence: a ras oncogene coexisting with altered myc genes in hematopoietic tumors
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4028963
retrieved
21 June 2018
All-trans retinoic acid as a differentiation therapy for acute promyelocytic leukemia. I. Clinical results
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4028963
retrieved
21 June 2018
A phase Ib GOELAMS study of the mTOR inhibitor RAD001 in association with chemotherapy for AML patients in first relapse.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4028963
retrieved
30 October 2018
The dual mTORC1 and mTORC2 inhibitor AZD8055 has anti-tumor activity in acute myeloid leukemia.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4028963
retrieved
30 October 2018
Inhibition of mTORC1 by RAD001 (everolimus) potentiates the effects of 1,25-dihydroxyvitamin D(3) to induce growth arrest and differentiation of AML cells in vitro and in vivo
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4028963
retrieved
30 October 2018
Protein synthesis is resistant to rapamycin and constitutes a promising therapeutic target in acute myeloid leukemia.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4028963
retrieved
30 October 2018
Translational control of c-MYC by rapamycin promotes terminal myeloid differentiation
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4028963
retrieved
30 October 2018
Novel t(5;9)(q33;q22) fuses ITK to SYK in unspecified peripheral T-cell lymphoma
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4028963
retrieved
30 October 2018
Antileukemic activity of rapamycin in acute myeloid leukemia.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4028963
retrieved
30 October 2018
Impaired myelopoiesis in mice lacking the repressors of translation initiation, 4E-BP1 and 4E-BP2
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/23535559
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
Temsirolimus, an mTOR inhibitor, in combination with lower-dose clofarabine as salvage therapy for older patients with acute myeloid leukaemia: results of a phase II GIMEMA study (AML-1107)
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/23535559
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
Gene expression-based high-throughput screening(GE-HTS) and application to leukemia differentiation
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/23535559
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
Detection of allele-specific expression of N-RAS oncogenes in human leukaemia cells
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/23535559
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
Spleen tyrosine kinase (Syk), a novel target of curcumin, is required for B lymphoma growth
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/23535559
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
Phospholipase D2-derived phosphatidic acid binds to and activates ribosomal p70 S6 kinase independently of mTOR
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/23535559
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
Identifiers
DOI
10.1038/LEU.2013.89
1 reference
stated in
Europe PubMed Central
PMC publication ID
4028963
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23535559%20AND%20SRC:MED&resulttype=core&format=json
retrieved
27 February 2020
Dimensions Publication ID
1015460305
0 references
PMC publication ID
4028963
1 reference
stated in
Europe PubMed Central
PMC publication ID
4028963
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23535559%20AND%20SRC:MED&resulttype=core&format=json
retrieved
27 February 2020
PubMed publication ID
23535559
1 reference
stated in
Europe PubMed Central
PMC publication ID
4028963
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23535559%20AND%20SRC:MED&resulttype=core&format=json
retrieved
27 February 2020
ResearchGate publication ID
236087026
0 references
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit